Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Guzauskas, Gregory F.
55  Ergebnisse:
Personensuche X
?
1

The value-based price of transformative gene therapy for si..:

Morgan, George ; Back, Emily ; Besser, Martin..
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

The long‐term impact and value of curative therapy for HIV:..:

Guzauskas, Gregory F. ; Hallett, Timothy B.
Journal of the International AIDS Society.  26 (2023)  9 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
3

Cost-effectiveness of population-wide genomic screening for..:

Guzauskas, Gregory F. ; Jiang, Shangqing ; Garbett, Shawn...
Genetics in Medicine.  24 (2022)  5 - p. 1017-1026 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Cost-effectiveness of population-wide genomic screening for..:

Spencer, Scott J. ; Jones, Laney K. ; Guzauskas, Gregory F....
Journal of Clinical Lipidology.  16 (2022)  5 - p. 667-675 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Budget impact analysis of the DiviTum TKa assay in postmeno..:

Carlson, Josh J. ; Guzauskas, Gregory F. ; Dann, Robert A..
Journal of Medical Economics.  24 (2021)  1 - p. 1309-1317 , 2021
Link: https://doi.org/10.1080/..
 
?
6

IBCL-199: Cost-Effectiveness of Obinutuzumab Plus Chemother..:

Veenstra, David L. ; Guzauskas, Gregory F. ; Spencer, Scott J....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S280 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Tumor treating fields and maintenance temozolomide for newl..:

Guzauskas, Gregory F. ; Pollom, Erqi L. ; Stieber, Volker W...
Journal of Medical Economics.  22 (2019)  10 - p. 1006-1013 , 2019
Link: https://doi.org/10.1080/..
 
?
8

Are There Different Evidence Thresholds for Genomic Versus ..:

Guzauskas, Gregory F. ; Basu, Anirban ; Carlson, Josh J..
Value in Health.  22 (2019)  9 - p. 988-994 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Influence of Modeling Choices on Value of Information Analy..:

Kim, David D. ; Guzauskas, Gregory F. ; Bennette, Caroline S....
PharmacoEconomics.  38 (2019)  2 - p. 171-179 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Integrating value of research into NCI Clinical Trials Coop..:

Carlson, Josh J. ; Kim, David D. ; Guzauskas, Gregory F....
Cancer Medicine.  7 (2018)  9 - p. 4251-4260 , 2018
Link: https://doi.org/10.1002/..
 
?
11

Estimated lifetime survival benefit of tumor treating field..:

Guzauskas, Gregory F ; Salzberg, Marc ; Wang, Bruce CM
CNS Oncology.  7 (2018)  3 - p. , 2018
Link: https://doi.org/10.2217/..
 
?
12

What is the value of conducting a trial of r-tPA for the tr..:

Guzauskas, Gregory F ; Chen, Er ; Lalla, Deepa...
International Journal of Stroke.  12 (2016)  2 - p. 137-144 , 2016
Link: https://doi.org/10.1177/..
 
?
13

Stakeholder perspectives on decision-analytic modeling fram..:

Guzauskas, Gregory F. ; Garrison, Louis P. ; Stock, Jacquie...
Genetics in Medicine.  15 (2013)  1 - p. 84-87 , 2013
Link: https://doi.org/10.1038/..
 
?
14

Microdeletion at 4q21.3 is associated with intellectual dis..:

Dukes‐Rimsky, Lynn ; Guzauskas, Gregory F. ; Holden, Kenton R....
American Journal of Medical Genetics Part A.  155 (2011)  9 - p. 2146-2153 , 2011
Link: https://doi.org/10.1002/..
 
?
15

tSNP-based identification of allelic loss of gene expressio..:

Guzauskas, Gregory F. ; Ukadike, Kennedy ; Rimsky, Lynn.
Genomics.  89 (2007)  4 - p. 562-565 , 2007
Link: https://doi.org/10.1016/..
 
1-15